Cite
Lian Y, Yan C, Ding J, et al. A novel lncRNA, LL22NC03-N64E9.1, represses KLF2 transcription through binding with EZH2 in colorectal cancer. Oncotarget. 2017;8(35):59435-59445doi: 10.18632/oncotarget.19738.
Lian, Y., Yan, C., Ding, J., Xia, R., Ma, Z., Hui, B., Ji, H., Zhou, J., & Wang, K. (2017). A novel lncRNA, LL22NC03-N64E9.1, represses KLF2 transcription through binding with EZH2 in colorectal cancer. Oncotarget, 8(35), 59435-59445. https://doi.org/10.18632/oncotarget.19738
Lian, Yifan, et al. "A novel lncRNA, LL22NC03-N64E9.1, represses KLF2 transcription through binding with EZH2 in colorectal cancer." Oncotarget vol. 8,35 (2017): 59435-59445. doi: https://doi.org/10.18632/oncotarget.19738
Lian Y, Yan C, Ding J, Xia R, Ma Z, Hui B, Ji H, Zhou J, Wang K. A novel lncRNA, LL22NC03-N64E9.1, represses KLF2 transcription through binding with EZH2 in colorectal cancer. Oncotarget. 2017 Jul 31;8(35):59435-59445. doi: 10.18632/oncotarget.19738. eCollection 2017 Aug 29. PMID: 28938648; PMCID: PMC5601744.
Copy
Download .nbib